Objective-In diabetes, long-term micro-and macrovascular damage often underlies the functional decline in the cardiovascular system. However, it remains unclear whether early-stage diabetes is associated with in vivo functional impairment in the coronary microvasculature. Synchrotron imaging allows us to detect and quantify regional differences in resistance microvessel caliber in vivo, even under conditions of high heart rate. Methods and Results-Synchrotron cine-angiograms of the coronary vasculature were recorded using anesthetized Sprague-Dawley rats 3 weeks after treatment with vehicle or streptozotocin (diabetic). In the early diabetic state, in the presence of nitric oxide and prostacyclin, vessel diameters were smaller (PϽ0.01) and endothelium-dependent vessel recruitment was already depressed (PϽ0.05). Endothelium-dependent and -independent vasodilatory responses in individual coronary vessels were not different in vivo. Inhibition of NO and PGI 2 production in diabetes uncovered early localized impairment in dilation. Diabetic animals displayed focal stenoses and segmental constrictions during nitric oxide synthase/cyclooxygenase blockade, which persisted during acetylcholine infusion (PϽ0.05), and a strong trend toward loss of visible microvessels. Conclusion-Synchrotron imaging provides a novel method to investigate coronary microvascular function in vivo at all levels of the arterial tree. Furthermore, we have shown that early-stage diabetes is associated with localized coronary microvascular endothelial dysfunction. (Arterioscler Thromb Vasc Biol. 2012;32:370-377.)
D
iabetes is associated with a 2-to 5-fold higher risk of cardiovascular disease relative to nondiabetics. 1 This is strongly linked to persistent long-term vascular damage occurring at both micro-and macro-vascular levels. 2 The coronary circulation, in particular, is known to be vulnerable to the diabetic milieu and develops endothelial dysfunction, independently of atherosclerosis. 3 The exact mechanisms leading to impaired coronary vascular function remain unclear. Previous work suggests that an imbalance develops between vasodilatory factors acting via the endothelium including nitric oxide (NO), prostacyclin (PGI 2 ), and endothelium-derived hyperpolarizing factors (EDHF) and vasoconstrictor factors. 2 Prior work indicates that in the later stages of diabetes, chronic hyperglycemia and hyperlipidemia result in increased oxidative stress and inflammation. 2 Reactive oxygen species (ROS) acting either directly or indirectly on the endothelium may thus cause impairment in the vasodilatory capacity of the coronary vessels. 4, 5 Although well-characterized in the later stages of diabetes, 6, 7 fewer studies have focused on the development of coronary dysfunction in the early period, where proactive interventional treatment may be more efficacious.
Some studies do suggest that endothelial function is maintained in the early hyperglycemic stage with no noticeable impairment of vasomotor function in coronary arteries. 8, 9 However, these in vitro studies have tended to focus on the large conductance arteries. Current clinical imaging devices used for the assessment of endothelial function, are limited to arterial and venous vessel sizes of greater than 200 m, with lengthy acquisition times of 30 to 100 ms. 10 This poses a problem, because in most organ systems the resistance vessels of interest in disease states are 100 m or smaller. 11 Using synchrotron radiation microangiography we have recently developed novel methods to repeatedly visualize the resistance vessels of the microcirculation (30 -100 m, small arteries-arterioles) in vivo 12, 13 and quantify regional differences in caliber over the entire cardiac phase, even under conditions of high heart rate (Ͼ500 bpm). 14 In this study our aims were (1) to validate a new approach for in vivo assessment of endothelial coronary function using synchro-tron radiation contrast angiography and (2) to investigate the early origins of vascular dysfunction in individual coronary microvessels using the streptozotocin-induced diabetic rat.
Methods
An expanded Methods section appears in the Supplemental Material, available online at http://atvb.ahajournals.org.
Animals and Experiments at the Synchrotron
All experiments were conducted at SPring-8, Japan Synchrotron Radiation Research Institute in Hyogo, Japan. Male Sprague Dawley rats (Japan SLC, Kyoto, Japan, 7 weeks old) received either a vehicle injection of sodium citrate (0.1 mol/L, pH 4) (control) or streptozotocin (65 mg/kg ip.) to induce type I diabetes. Three weeks after vehicle or streptozotocin injection all rats underwent terminal experiments.
Angiography Protocol
Iodinated contrast medium (Iomeron 350; Bracco-Eisai Co. Ltd, Tokyo, Japan) was injected intra-arterially as a bolus (0.2-0.5 mL at 0.4 mL/s) into the aorta and cine-radiograms were obtained over 3 s during a temporary cessation of ventilation. A small arterial pressure drop (Ϸ10 mmHg) that occurred when ventilation was interrupted was counterbalanced by an increase in pressure during bolus entry (5-10 mmHg). Bolus injection did not cause a significant pressure perturbation during image sequences.
Experimental Protocol
Endothelium-dependent and -independent vasodilatory responses were recorded in control (nϭ5) and diabetic (nϭ6) animals. This was achieved by recording coronary angiograms during infusions of vehicle (lactate 3.0 mL/h), acetylcholine (ACh; 3.0 g/kg/min), sodium nitroprusside (SNP; 3.0 g/kg/min), during lactate infusion 30 minutes after nitric oxide synthase (NOS) inhibition with Nnitro-l-arginine methyl ester (L-NAME; 50 mg/kg iv. bolus), and 15 minutes after further cyclooxygenase (COX) inhibition with sodium meclofenamate (3 mg/kg iv. bolus). Repeat imaging was performed after combined L-NAME ϩmeclofenamate treatment and a repeat infusion of ACh (3.0 g/kg/min). At the termination of experiments, rats were killed and their hearts removed and fixed in 10% formaldehyde.
Histology and Immunohistochemistry
Perivascular fibrosis expression was evaluated in coronary arterioles of picrosirus red stained LV sections. Immunohistochemical staining was performed against murine-specific endothelial cell marker isolectin B4 (1:50, Vector Laboratories, Burlingame, CA) to assess capillary density. Automatic quantification was made using predefined algorithms on Aperio Imagescope (v11.0.2.725, Aperio Technologies, CA).
Assessment of Vessel Internal Diameter
Quantitative analysis of vessel internal diameter (ID) was based on measurements from the middle of discrete vessel segments in individual cine-radiograms using Image-J (v1.41, National Institutes of Health, Bethesda, MD). Angiograms presented in this article underwent median filtering (2 pixel radius) to improve vessel clarity for publication purposes only. Arterial vessels were categorized according to their branching order (root, 1 st , 2 nd , and 3 rd ) and their basal vessel ID size class (40 -100 m, 100 -200 m, 200 -300 m, and Ͼ300 m; Supplemental Figure II) . Reported results for vessel ID and vessel number during drug infusions are expressed as percentage change from baseline (⌬) to account for differences in absolute baseline vessel ID and vessel number between groups. Vessel recruitment was determined as the ⌬ in vessel number from baseline during each treatment for the same field of view.
Quantification of Focal and Segmental Vasoconstrictions
Localized focal vasoconstrictions were considered to be present when a small portion of a vessel segment showed a constricted ID less than 50% of upstream nonoccluded segment ID in the case of focal constrictions and less than 70% of baseline vessel ID in the case of segmental constrictions (most of segment length).
Statistical Analysis
Data are expressed as meanϮSEM unless otherwise stated. For each individual rat the mean vessel ID or mean ⌬ vessel ID (%) of each branching order was used for group comparisons. One-way and 2-way ANOVA with Bonferroni correction were carried out to assess within-and between-group differences, followed by a 2-tailed Student t-test to determine statistical significance between groups. The Statistical Package Software System (SPSS v15, SPSS, Chicago, IL) was used for all analysis with values of PϽ0.05 deemed significant.
Results

Animal Characteristics
Diabetic rats had significantly higher blood glucose concentration and lower final body weight compared to controls (PϽ0.001, Table) . Mean arterial pressure (MAP), measured prior to imaging, was Ϸ40 mmHg lower in diabetics rats (PϽ0.05) although heart rate was comparable to controls (Table) . Myocardial capillary density (Supplemental Figure 
Vessel Response to EndotheliumDependent/Independent Stimulation
Basal endothelium-dependent dilatory responses did not differ between control and diabetic animals with infusion of ACh, evoking similar vasodilatory responses in both control and diabetic rats on the basis of branching order ( Figure 2A ) and vessel class (Supplemental Figure IVA) . There was however a smaller decrease in MAP in diabetic animals in response to ACh (⌬ Ϫ9.7Ϯ5.7 versus Ϫ31.8Ϯ8.3%, PϽ0.05, Figure 3A ). Endothelium-independent dilation in vessels in response to SNP infusion was comparable between diabetic and control animals ( Figure 2B and Supplemental Figure  IVB ). Consistent with this response, MAP was reduced by a similar extent in both groups ( Figure 3A ).
Vessel Response During Vasodilator Inhibition
Blockade of NOS resulted in a slight increase in vessel ID in both groups ( Figure 2C and Supplemental Figure IVC) , whereas MAP was significantly increased in diabetic animals (⌬ 56.4Ϯ11.1, PϽ0.01, Figure 3A) . In control rats, combined NOS and COX blockade evoked a modest ID increase in all arteries and arterioles compared ( Figure 2D and Figure 4C ; black asterisk) to baseline ( Figure 4A ), most notably in the 40 to 100 m vessel class (Supplemental Figure IVD, PϽ0.01 ). Of significant note was the inability of the diabetic circulation to maintain vessel ID after COX blockade in combination with NOS inhibition ( Figure 4D ; white arrow and asterisk) compared to baseline ( Figure 4B ) with significant vasoconstriction in diabetic 100 to 200 m vessels versus controls (Supplemental Figure IVD, PϽ0.05 ). As MAP in diabetics was significantly higher than at baseline (⌬65.2Ϯ7.6%, PϽ0.01) and further was also higher than control (⌬20.4Ϯ7.1%, PϽ0.01, Figure 3A) , it is predicted that coronary perfusion pressure after NOS and COX blockade was also higher in diabetic rats relative to baseline. Because we cannot separate metabolic and endothelial roles in autoregulatory vasodilation in the face of a significant increase in pressure in diabetics we can only assume that both play significant roles as there was no significant compensatory decrease in heart rate. Contrast injection did not evoke a significant pressure perturbation during imaging. ACh-mediated vasodilation post-NOS and COX blockade was normal with similar dilation across medium and small vessel classes in control ( Figure 2E and Figure 4E ; black arrow, Supplemental Figure IVE ) and diabetic animals ( Figures  2E and 4F , and Supplemental Figure IVE) .
Vessel Recruitment During Endothelium Stimulation
Vessel number was significantly lower in diabetic animals during the first ACh infusion (⌬25.8Ϯ16.1% versus Ϫ19.9Ϯ12.4%, PϽ0.05) compared to controls, but not during SNP ( Figure 3B ). NOS blockade alone caused no significant difference in visible vessels in either group. However with further blockade of COX, there was a strong trend toward reduced visible microvessels in diabetic rats compared to controls (Pϭ0.059, Figure 3B ). Vessel number remained lower in diabetics compared to controls following postblockade infusion of ACh; however this was not significantly different between the 2 groups ( Figure 3B ).
Localized Vascular Constrictions Assessment
No focal constrictions were observed in any control animals. In contrast focal constrictions in diabetic animals were observed during NOS blockade and their incidence increased after further COX inhibition ( Figure 4D ; dashed black arrows insert, Figure 5A , and Supplemental Movie I). Mean vessel occlusion was 63.8% and 66.2Ϯ1.1% of upstream nonconstricted vessel ID during NOS blockade and combined blockade, respectively. Notably, severe focal constrictions were primarily located at branching points of the secondary and tertiary conduits (Supplemental Figure VA , asterisk) and were present over the entire cardiac cycle as demonstrated in Supplemental Figure VB . Importantly, these constrictions persisted following ACh administration, as depicted in Figure  5A , although the mean vessel occlusion lessened slightly to 61.7Ϯ2.1% of upstream nonoccluded vessel ID ( Figure 4F ; black arrows).
The percentage of vessels classified as being segmentally constricted relative to baseline was not significantly different in control and diabetic animals during endothelium-dependent and -independent stimulation ( Figure 5B ). This was also the case during NOS blockade alone. Following combined NOS/COX blockade, however, there was a strong trend toward a greater proportion of segmentally constricted vessels in diabetic compared to control animals ( Figure 5B ). Segmental constrictions occurred predominately in 2 nd -order vessels in both groups (Supplemental Figure VI) . Subsequent endothelial stimulation postblockade, completely abolished all segmental constrictions in controls but significantly was unable to do so in diabetics (PϽ0.05, Figure  4F ; white asterisk, Figure 5B 
Discussion
To the best of our knowledge, this is the first in vivo study to characterize early impairment in the diabetic coronary microvasculature in rodents using synchrotron radiation. Furthermore, our results show that EDHF-mediated vasodilation in the coronary resistance vessels is impaired prior to changes in NO and PGI 2 with 3 lines of evidence to support this conclusion. First, endothelium-dependent and -independent vasodilation responses were normal in diabetic rat hearts in the presence of NO and PGI 2 , but there was a reduction in endothelium-dependent vessel recruitment. Second, we showed an increased presence of focal and segmental constrictions in the conduit and resistance vessels of the coronary circulation of diabetic hearts after NOS and COX blockade. Furthermore, in the absence of NO and PGI 2 coronary constrictions were not alleviated by ACh stimulation.
This study investigated early structural changes in the diabetic coronary circulation and found no observable difference in capillary density or perivascular fibrosis, suggesting that a longer diabetic time course is required for impairment in coronary flow 3 and vessel loss 15 to become apparent. Myocardial perfusion and vascular elasticity are thus comparable to controls and would be assumed to be adequate for basal function. In this study the main endothelium-derived vasodilators, NO, PGI 2 , and EDHF, and their specific contributions were of principal interest. The exact identity of EDHF however is still unknown, with considerable evidence now suggesting that EDHF is not a single entity but rather a collection of factors 16 
Vascular Function in the Presence of Nitric Oxide and Prostacyclin
Mean arterial blood pressure was significantly lower in diabetic animals consistent with previous studies 21 smaller caliber, but a change in the balance of vasodilators and vasoconstrictors might also play a small role. 22 Our findings of normal basal function are in agreement with previous studies where 2 to 6 weeks of diabetes was insufficient to impair endothelium-dependent and -independent vascular function. 9, 23 The exact mechanism by which endothelial function is maintained in the face of hyperglycemia remains unclear, although recent work suggests that even in the presence of increased ROS in early diabetes, NO from non-NOS sources may stimulate soluble guanylate cyclase to open K ϩ channels and thus preserve dilation. 23 Although dilatory responses in diabetic animals were normal we did observe a smaller decrease in MAP in response to endothelial stimulation. This reduced responsiveness in mean arterial pressure may stem from impairment in endothelial function in other peripheral vascular beds, even though basal coronary endothelial function is normal. 24 There was also a concurrent reduction in endothelium-dependent opening of new vessels. Changes in vessel recruitment as assessed by the presence or absence of vessel contrast are indicative of altered resistance within these vessel segments. Thus, the inability of endothelium-dependent stimulation to evoke opening of vessel segments, suggests that diabetic vessels are unable to sufficiently reduce resistance to allow contrast perfusion. Hence, there appears to be early indications of impaired vessel responsiveness in resistance microvessels within the coronary circulation, even though vessel ID responses to endothelium-dependent stimulation were normal. However, we cannot preclude the possibility that in the diabetics there were no further arterial segments to recruit.
Basal EDHF and Reserve in the Absence of Nitric Oxide and Prostacyclin
There are few studies specifically investigating the contribution of EDHF to the coronary circulation in the early stages of diabetes, although EDHF downregulation in other vascular beds in the later stages of diabetes is well characterized. 25, 26 Imbalances in the production of endothelium-derived vasoconstrictors including endothelin-1 27 and COX-dependent vasoconstrictor factor 28 in the presence of increased vasoconstrictor influence, it may be insufficient to maintain vascular dilation. Responses to ACh post-NOS/COX blockade in diabetic vessels were similar to that observed in control rats, suggesting that vasodilation mediated by endothelial stimulation of EDHF was not widely impaired at this early stage of diabetes. Thus when stimulated, global EDHF reserve appears to be sufficient to overcome inherent vasoconstrictor tone in the absence of NO and PGI 2 production.
Focal and Segmental Constrictions
This in vivo study is one of the few to explore the presence of vasospasm in the early stages of diabetes when basal endothelial function, as discussed previously, is thought to be normal. Focal constrictions following NOS blockade were only noted in diabetics, whereas their incidence increased further following COX inhibition. In stark contrast, control rats have sufficient vasodilatory reserve to compensate for this loss and maintain vasodilatory capacity. These focal constrictions in diabetic rats may result from localized limitations in the ability of the dysfunctional coronary endothelium to produce vasodilators, including EDHF, as has been previously shown in the systemic circulation. 25, 26 Increased vasoconstrictor influence at highly localized sites within the diabetic coronary vasculature may also contribute. Furthermore, the RhoA/Rho-kinase pathway is known to be upregulated in the diabetic vasculature 29, 30 and has been implicated in the development of coronary artery spasm, [31] [32] [33] warranting further investigation. Endothelial stimulation post-NOS and COX blockade in diabetic rats, resulted in no change in focal constriction incidence, but a slightly reduced severity. Focal constrictions were however entirely absent in control animals. The persistence of focal constrictions during endothelium stimulation, provides further evidence that localized areas of the endothelium, even in the early stages of diabetes, are deficient in EDHF-mediated vasodilatory reserve. Coronary constrictions are most often observed in the human condition as a result of coronary artery disease. It is important to note however that rodents have cholesterol profiles dissimilar to humans and do not develop atherosclerosis. 34 Thus, the presence of these constrictions in diabetic rodents suggests that diabetes itself is the major cause of their development. In addition to focal constrictions, there was a strong trend toward increased segmental constrictions (Ͼ30% vessel ID constriction from baseline) in diabetic rats following NOS and COX inhibition. Although nonsignificant, this trend does support impaired diabetic basal EDHF function. More importantly however, endothelium stimulation post-NOS/COX blockade was unable to alleviate segmentally constricted vessels in diabetic animals, contrasting with the complete restoration of all previously constricted vessels in controls. This significant difference mirrors the response of diabetic focal constrictions and again implies that EDHF reserve in at risk diabetic coronary vessels is insufficient. This EDHF impairment may predispose the diabetic circulation toward reduced maximal perfusion and/or impose a greater cardiac work requirement for the maintenance of myocardial blood flow. 35 Furthermore, the importance of this reduced vasodilatory capacity becomes more apparent as the risk of myocardial infarction and stroke increases with diabetes progression. 36 
Possible Mechanisms of Early Vascular Dysfunction
Our data provides functional insights into the role of endothelium-derived vasodilators in diabetes. Increased ROS resulting from hyperglycemia 4 however, seems a prime unifying precursor as it has been shown to activate multiple pathways including increased COX-2 expression, 37 increased vasoconstrictor tone, 6, 38 and activation of RhoA/ROCK, 39 all discussed previously. Furthermore it is well-accepted that hyperglycemia causes vascular endothelial dysfunction, possibly through increased nonenzymatic glycosylation, in-A B Figure 5 . Focal (A) and segmental (B) constrictions in control and diabetic rats. Number of focal constrictions and proportion of segmental constrictions (% of total vessels visible) during administration of ACh, sodium nitroprusside (SNP), N-nitro-l-arginine methyl ester (L-NAME), combined L-NAMEϩmeclofenamate and combinedϩACh. Control, nϭ5, and diabetic, nϭ6. †PϽ0.05 vs control.
creased oxidative stress stemming from reactive oxygen and nitrogen species, and activation of protein kinase C and AMPK pathways. 40 
Synchrotron Radiation Imaging Benefits and Experimental Limitations
There have been a number of previous in vivo studies investigating changes in the coronary vasculature using synchrotron radiation; [41] [42] [43] however, this technique has not been used to investigate early changes in the diabetic coronary circulation. Coronary microangiography using synchrotron radiation permits the assessment of microvascular function in vivo, in real time even during conditions of high heart rate (Ͼ500 bpm) due to its ability to be performed in time orders as low as 1 ms shutter open-times. 14 Furthermore, compared to conventional imaging methods, including CT and MRI, synchrotron radiation allows the assessment of microvascular ID and spasms Ͻ100 m, which would normally require the hearts to be arrested prior to imaging. 44 Synchrotron radiation also enables within-animal assessment of individual arteries, as only minimal contrast boluses are needed due to high photon flux and collimation resulting from its "point source" emission. 14 On the other hand, currently direct application of this technology to imaging patients is limited by facility access. The number of medical imaging beam lines at synchrotron radiation facilities is increasing, but access is limited by competitive merit-based proposal systems. Hence, routine diagnostic imaging of diabetic patients at these facilities is highly unlikely. However, these authors are aware of at least 2 international research efforts in Europe and Japan to produce synchrotron radiation sources small enough to fit within clinics for medical imaging and radiotherapy purposes. Improved X-ray flux and collimation could conceivably improve the diagnostic detection of early diabetic vascular dysfunction as reported in this study.
Summary
In summary, synchrotron radiation microangiography provides a novel in vivo method for investigating the progression of coronary microvascular disease. In the early diabetic state our results suggest that baseline vessel response is relatively normal although the depressed endothelium-dependent vessel recruitment suggests that this is already rapidly changing. Furthermore, using this within-segment analysis technique we have uncovered localized focal and segmental constrictions during vasodilator inhibition in the early diabetic microvasculature suggesting specific impairment in EDHF function. These findings provide a strong basis for further investigation into the early pathophysiological changes that occur in this increasingly prevalent disease state.
